First report of cutaneous mycetoma by Paecilomyces variotii and the successful treatment with combined itraconazole and terbinafine along with resection surgeries

Mycetoma is a progressively mutilating infectious disease of the subcutaneous tissue that affects the skin and deep structures, which is poorly responsive to chemotherapy. Here, we report a skin mycetoma caused by Paecilomyces variotii, an uncommon fungus of human infections, and the therapeutic approach that resulted in a complete cure of the patient.

[1]  N. Litaiem,et al.  [Eumycetoma]. , 2021, La Revue du praticien.

[2]  R. Domingos,et al.  A Case of Pulmonary Mycetoma Caused by Paecilomyces variotii , 2019, European journal of case reports in internal medicine.

[3]  A. Jha,et al.  Mycetoma: reviewing a neglected disease , 2018, Clinical and experimental dermatology.

[4]  B. Buchan,et al.  Treatment of Paecilomyces variotii pneumonia with posaconazole: case report and literature review , 2016, Mycoses.

[5]  M. Goodfellow,et al.  Mycetoma: a unique neglected tropical disease. , 2016, The Lancet. Infectious diseases.

[6]  P. Tabarsi,et al.  Pulmonary Paecilomyces in a Diabetic Patient , 2015, Tanaffos.

[7]  R. Verma,et al.  First reported case of subcutaneous hyalohyphomycosis caused by Paecilomyces variotii , 2013, International journal of dermatology.

[8]  L. Goldani,et al.  Paecilomyces variotii as an Emergent Pathogenic Agent of Pneumonia , 2013, Case reports in infectious diseases.

[9]  E. Zijlstra,et al.  The safety and efficacy of itraconazole for the treatment of patients with eumycetoma due to Madurella mycetomatis. , 2011, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[10]  J. Guarro,et al.  In Vitro Interactions of Approved and Novel Drugs against Paecilomyces spp , 2004, Antimicrobial Agents and Chemotherapy.